Halozyme Therapeutics Comprehensive Income 2010-2024 | HALO

Halozyme Therapeutics comprehensive income for the quarter ending September 30, 2024 was $-0.007B, a 665.53% decline year-over-year.

  • Halozyme Therapeutics comprehensive income for 2023 was $-0.009B, a 906.29% increase from 2022.
  • Halozyme Therapeutics comprehensive income for 2022 was $-0.001B, a 48.71% increase from 2021.
  • Halozyme Therapeutics comprehensive income for 2021 was $-0.001B, a 2918.18% decline from 2020.

Halozyme Therapeutics Comprehensive Income 2010-2024 | HALO

  • Halozyme Therapeutics comprehensive income for 2023 was $-0.009B, a 906.29% increase from 2022.
  • Halozyme Therapeutics comprehensive income for 2022 was $-0.001B, a 48.71% increase from 2021.
  • Halozyme Therapeutics comprehensive income for 2021 was $-0.001B, a 2918.18% decline from 2020.